Lupin Limited
LUPIN
Rank in Stocks
#2146
Lupin Limited is a pharmaceutical firm dedicated to the creation,... Lupin Limited is a pharmaceutical firm dedicated to the creation, manufacturing, commercialization, and distribution of a wide array of branded and generic medications, biotechnology items, and active pharmaceutical ingredients (APIs). Its comprehensive product portfolio addresses diverse therapeutic categories, including cardiovascular health, diabetes management, asthma, pediatric care, central nervous system disorders, gastrointestinal issues, anti-infectives, nonsteroidal anti-inflammatory drug (NSAID) therapy, respiratory ailments, women's health, and anti-tuberculosis treatments. Beyond its primary offerings, Lupin also supplies biosimilars and over-the-counter (OTC) medicines, alongside specialized pharmaceutical products. The company actively pursues drug discovery and development initiatives focused on oncology, immunology, and metabolic disorders, complementing these efforts with bio-clinical research. Lupin Limited maintains an extensive operational network comprising 18 laboratories, 280 LupiMitra collection centers, and 450 pick-up points. Its global presence extends across numerous countries, such as India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. Originally named Lupin Chemicals Limited, the company adopted its current identity, Lupin Limited, in 2001 following its merger with Lupin Laboratories Limited. Established in 1968, Lupin Limited is based in Mumbai, India.
Share Price
$20.35
Market Cap
$9.30B
Change (1 day)
-5.06%
Change (1 year)
-7.79%
Country
IN
Trade Lupin Limited (LUPIN)
Category
Healthcare
Stock price history for Lupin Limited (LUPIN)
Highest end of day price: $21.67 on 2026-10-01
Lowest end of day price: $0.15 on 2001-09-01
Lowest end of day price: $0.15 on 2001-09-01
Stock price history of Lupin Limited from 2001 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | 4.87% |
| 2025 | -7.64% |
| 2024 | 65.92% |
| 2023 | 66.87% |
| 2022 | -23.57% |
| 2021 | -7.86% |
| 2020 | 20.18% |
| 2019 | -9.99% |
| 2018 | -9.76% |
| 2017 | -39.41% |
| 2016 | -19.49% |
| 2015 | 18.35% |
| 2014 | 59.89% |
| 2013 | 29.56% |
| 2012 | 32.51% |
| 2011 | -19.07% |
| 2010 | 66.57% |
| 2009 | 159.72% |
| 2008 | -20.92% |
| 2007 | 17.92% |
| 2006 | 53.29% |
| 2005 | 5.97% |
| 2004 | -2.10% |
| 2003 | 510.86% |
| 2002 | 19.06% |
| 2001 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
